Asacol
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Abstract Objective. Post-infective irritable bowel syndrome (PI-IBS) is characterized by continuing symptoms of irritable bowel…
Introduction Mesalazine has traditionally been administered in divided doses, but there is emerging evidence that once daily…
Asacol, a medication that delivers delayed release 5-aminosalicylic acid (5-ASA), is a useful therapeutic agent for inflammatory…
IntroductionThe pharmacokinetics and safety of Asacol® (Tillotts Pharma AG, Ziefen, Switzerland), which has been used worldwide…
Backround 5‐ASA in a pH sensitive tablet (Asacol) is administered as three doses/day to treat ulcerative colitis. Once daily…
Background : 5‐Aminosalicylates remain important in the treatment of ulcerative colitis, but it is uncertain if the various…
BACKGROUND
The aim of our study was to analyze drug-induced liver disease over a 3-year period in one gastroenterological…
To compare the efficacy of Asacol (mesalazine coated with Eudraget-S) as a maintenance therapy with that of sulphasalazine…